{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:09:48Z","timestamp":1773968988364,"version":"3.50.1"},"reference-count":41,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00005-019-00537-6","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T07:18:22Z","timestamp":1554362302000},"page":"161-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression"],"prefix":"10.2478","volume":"67","author":[{"given":"Asmaa M.","family":"Zahran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona H.","family":"Abdel-Rahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid I.","family":"Elsayh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal M.","family":"Hassanien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safaa A.","family":"Mahran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-7304","authenticated-orcid":false,"given":"Helal F.","family":"Hetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"537_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916930290005864","volume":"35","author":"AG Baxter","year":"2002","unstructured":"Baxter AG, Smyth MJ (2002) The role of NK cells in autoimmune disease. Autoimmunity 35:1\u201314","journal-title":"Autoimmunity"},{"key":"537_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri MA (2008) Human natural killer cells. Blood 112:461\u2013469","journal-title":"Blood"},{"key":"537_CR3","first-page":"206731","volume":"2015","author":"J Chen","year":"2015","unstructured":"Chen J, Wu M, Wang J et al (2015) Immunoregulation of NKT cells in systemic lupus erythematosus. J Immunol Res 2015:206731","journal-title":"J Immunol Res"},{"key":"537_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/rheumatology\/keq457","volume":"50","author":"YN Cho","year":"2011","unstructured":"Cho YN, Kee SJ, Lee SJ et al (2011) Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity. Rheumatology 50:1054\u20131063","journal-title":"Rheumatology"},{"key":"537_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1191\/0961203302lu190sa","volume":"11","author":"NA Dayal","year":"2002","unstructured":"Dayal NA, Gordon C, Tucker L et al (2002) The SLICC damage index: past, present and future. Lupus 11:261\u2013265","journal-title":"Lupus"},{"key":"537_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/0961203306069972","volume":"15","author":"K Leeuw de","year":"2006","unstructured":"de Leeuw K, Freire B, Smit AJ et al (2006) Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. Lupus 15:675\u2013682","journal-title":"Lupus"},{"key":"537_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ni.1841","volume":"11","author":"DI Godfrey","year":"2010","unstructured":"Godfrey DI, Stankovic S, Baxter AG (2010) Raising the NKT cell family. Nat Immunol 11:197\u2013206","journal-title":"Nat Immunol"},{"key":"537_CR8","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.4049\/jimmunol.154.11.5656","volume":"154","author":"JD Gray","year":"1995","unstructured":"Gray JD, Horwitz DA (1995) Activated human NK cells can stimulate resting B cells to secrete immunoglobulin. J Immunol 154:5656\u20135664","journal-title":"J Immunol"},{"key":"537_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/art.22326","volume":"56","author":"MR Green","year":"2007","unstructured":"Green MR, Kennell AS, Larche MJ et al (2007) Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production. Arthritis Rheum 56:303\u2013310","journal-title":"Arthritis Rheum"},{"key":"537_CR10","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/art.22048","volume":"54","author":"R Gutierrez-Suarez","year":"2006","unstructured":"Gutierrez-Suarez R, Ruperto N, Gastaldi R et al (2006) A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 54:2989\u20132996","journal-title":"Arthritis Rheum"},{"key":"537_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3109\/14397595.2013.844309","volume":"24","author":"D Gutowska-Owsiak","year":"2014","unstructured":"Gutowska-Owsiak D, Birchall MA, Moots RJ et al (2014) Proliferatory defect of invariant population and accumulation of non-invariant CD1d-restricted natural killer T cells in the joints of RA patients. Mod Rheumatol 24:434\u2013442","journal-title":"Mod Rheumatol"},{"key":"537_CR12","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.4049\/jimmunol.179.7.4513","volume":"179","author":"H Harlin","year":"2007","unstructured":"Harlin H, Hanson M, Johansson CC et al (2007) The CD16\u2212 CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset. J Immunol 179:4513\u20134519","journal-title":"J Immunol"},{"key":"537_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10067-013-2176-8","volume":"32","author":"A Henriques","year":"2013","unstructured":"Henriques A, Teixeira L, In\u00eas L et al (2013) NK cells dysfunction in systemic lupus erythematosus: relation to disease activity. Clin Rheumatol 32:805\u2013813","journal-title":"Clin Rheumatol"},{"key":"537_CR14","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"537_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s100670170023","volume":"20","author":"P Horak","year":"2001","unstructured":"Horak P, Scudla V, Hermanovo Z et al (2001) Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus. Clin Rheumatol 20:337\u2013344","journal-title":"Clin Rheumatol"},{"key":"537_CR16","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.4049\/jimmunol.1000569","volume":"186","author":"Z Huang","year":"2011","unstructured":"Huang Z, Fu B, Zheng SG et al (2011) Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus. J Immunol 186:3421\u20133431","journal-title":"J Immunol"},{"key":"537_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.it.2005.08.008","volume":"26","author":"S Johansson","year":"2005","unstructured":"Johansson S, Berg L, Hall H et al (2005) NK cells: elusive players in autoimmunity. Trends Immunol 26:613\u2013618","journal-title":"Trends Immunol"},{"key":"537_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nri854","volume":"2","author":"M Kronenberg","year":"2002","unstructured":"Kronenberg M, Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2:557\u2013568","journal-title":"Nat Rev Immunol"},{"key":"537_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/0961203308098191","volume":"18","author":"A Cava La","year":"2009","unstructured":"La Cava A (2009) Lupus and T cells. Lupus 18:196\u2013201","journal-title":"Lupus"},{"key":"537_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.autrev.2005.04.008","volume":"4","author":"A Cava La","year":"2005","unstructured":"La Cava A, Fang CJ, Singh RP et al (2005) Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev 4:515\u2013519","journal-title":"Autoimmun Rev"},{"key":"537_CR21","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1586\/erv.09.56","volume":"8","author":"ML Lang","year":"2009","unstructured":"Lang ML (2009) How do natural killer T cells help B cells? Expert Rev Vaccines 8:1109\u20131121","journal-title":"Expert Rev Vaccines"},{"key":"537_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.kint.2017.02.006","volume":"92","author":"BMP Law","year":"2017","unstructured":"Law BMP, Wilkinson R, Wang X et al (2017) Interferon-gamma production by tubulointerstitial human CD56(bright) natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Kidney Int 92:79\u201388","journal-title":"Kidney Int"},{"key":"537_CR23","doi-asserted-by":"publisher","first-page":"e0186223","DOI":"10.1371\/journal.pone.0186223","volume":"12","author":"SJ Lin","year":"2017","unstructured":"Lin SJ, Kuo ML, Hsiao HS et al (2017) Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15. PLoS One 12:e0186223","journal-title":"PLoS One"},{"key":"537_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2011.01.013","volume":"34","author":"T Mallevaey","year":"2011","unstructured":"Mallevaey T, Clarke AJ, Scott-Browne JP et al (2011) A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34:315\u2013326","journal-title":"Immunity"},{"key":"537_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1542\/peds.109.1.45","volume":"109","author":"CL Ogden","year":"2002","unstructured":"Ogden CL, Kuczmarski RJ, Flegal KM et al (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45\u201360","journal-title":"Pediatrics"},{"key":"537_CR26","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/art.24556","volume":"60","author":"YW Park","year":"2009","unstructured":"Park YW, Kee SJ, Cho YN et al (2009) Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 60:1753\u20131763","journal-title":"Arthritis Rheum"},{"key":"537_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Theresine M et al (2009) CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126:458\u2013465","journal-title":"Immunology"},{"key":"537_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1053\/beem.2002.0182","volume":"16","author":"J Pozo","year":"2002","unstructured":"Pozo J, Argente J (2002) Delayed puberty in chronic illness. Best Pract Res Clin Endocrinol Metab 16:73\u201390","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"537_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/BOR.0000000000000085","volume":"26","author":"V Rao","year":"2014","unstructured":"Rao V, Gordon C (2014) Advances in the assessment of lupus disease activity and damage. Curr Opin Rheumatol 26:510\u2013519","journal-title":"Curr Opin Rheumatol"},{"key":"537_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1191\/096120300678828460","volume":"9","author":"V Riccieri","year":"2000","unstructured":"Riccieri V, Spadaro A, Parisi G et al (2000) Down-regulation of natural killer cells and of gamma\/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity? Lupus 9:333\u2013337","journal-title":"Lupus"},{"key":"537_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","volume":"126","author":"D Schepis","year":"2009","unstructured":"Schepis D, Gunnarsson I, Eloranta ML et al (2009) Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology 126:140\u2013146","journal-title":"Immunology"},{"key":"537_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","volume":"98","author":"R Spada","year":"2015","unstructured":"Spada R, Rojas JM, Barber DF (2015) Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol 98:479\u2013487","journal-title":"J Leukoc Biol"},{"key":"537_CR33","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/rheumatology\/kex078","volume":"56","author":"V Stratigou","year":"2017","unstructured":"Stratigou V et al (2017) Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity. Rheumatology 56:1206\u20131216","journal-title":"Rheumatology"},{"key":"537_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev.immunol.21.120601.141057","volume":"21","author":"M Taniguchi","year":"2003","unstructured":"Taniguchi M, Harada M, Kojo S et al (2003) The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21:483\u2013513","journal-title":"Annu Rev Immunol"},{"key":"537_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0022-3476(85)80501-1","volume":"107","author":"JM Tanner","year":"1985","unstructured":"Tanner JM, Davies PS (1985) Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 107:317\u2013329","journal-title":"J Pediatr"},{"key":"537_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jocit.2016.03.001","volume":"2","author":"S Tsakas","year":"2016","unstructured":"Tsakas S, Marinaki E, Eleftheriadis T et al (2016) Alterations of natural killer cell count, activation capability and cytotoxicity, in glomerulonephritis. Cell Immunol Immunother 2:1\u20136","journal-title":"Cell Immunol Immunother"},{"key":"537_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2004.03.003","volume":"112","author":"HJ Vliet van der","year":"2004","unstructured":"van der Vliet HJ, Molling JW, von Blomberg BM et al (2004) The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin Immunol 112:8\u201323","journal-title":"Clin Immunol"},{"key":"537_CR38","volume-title":"An evaluation of infant growth","author":"WHO Working Group on Infant Growth","year":"1994","unstructured":"WHO Working Group on Infant Growth (1994) An evaluation of infant growth. World Health Organization, Geneva"},{"key":"537_CR39","unstructured":"World Health Organization (1995) Physical status: The use of and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854, Geneva, Switzerland"},{"key":"537_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/156652409787314534","volume":"9","author":"L Wu","year":"2009","unstructured":"Wu L, Van Kaer L (2009) Natural killer T cells and autoimmune disease. Curr Mol Med 9:4\u201314","journal-title":"Curr Mol Med"},{"key":"537_CR41","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1681\/ASN.2007101117","volume":"19","author":"SH Yang","year":"2008","unstructured":"Yang SH, Kim SJ, Kim N et al (2008) NKT cells inhibit the development of experimental crescentic glomerulonephritis. J Am Soc Nephrol 19:1663\u20131671","journal-title":"J Am Soc Nephrol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00537-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-019-00537-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00537-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:13Z","timestamp":1704228553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-019-00537-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s00005-019-00537-6","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"3 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}